Evaluation of the relationship between bone mineral density and parameters of subclinical atherosclerosis in a prospective study of postmenopausal women

Aim. To study the relationships between vascular wall parameters and bone mineral density (BMD) over a 10-year period.

Material and methods. The study included 93 menopausal women without clinical manifestations of atherosclerosis at the baseline stage, who underwent outpatient examination twice with an interval of 10 years. Measurement of pulse wave velocity and augmentation index (AI) using applanation tonometry, carotid ultrasound to determine the intima-­media thickness (IMT) and register plaques, and measurement of BMD using dual-energy X-ray absorptiometry were performed at both visits.

Results. Over a 10-year period, an increase in AI, IMT, and plaque count (p<0,001) and a decrease in BMD were noted in the femoral neck and proximal femur (p<0,001), but not in the spine. Multivariate regression analysis adjusted for factors identified at the baseline visit (age, postmenopause duration, body mass index, hypertension, and cardiovascular and osteoporosis therapy) showed that AI, IMT, and plaque presence independently contributed to the decrease in bone mass. Pulse wave velocity and the number of atherosclerotic plaques did not act as independent factors in the decrease in BMD.

Conclusion. Over a long period of time, a stable negative association was maintained between AI, IMT, the plaque presence, and bone mass, which did not depend on fracture and cardiovascular risk factors, as well as the use of antiresorptive and cardiovascular therapy.

1. Oganov RG, Maslennikova GYa. Demographic trends in the Russian Federation: the contribution of circulatory diseases. Cardiovascular Therapy and Prevention. 2012;11(1):5-10. (In Russ.) doi:10.15829/1728-8800-2012-1-5-10.

2. Lesnyak OM, Baranova IA, Belova KYu, et al. Osteoporosis in the Russian Federation: epidemiology, medical, social and economic aspects of the problem (literature review). Traumatology and orthopedics of Russia. 2018;24(1):155-68. (In Russ.) doi:10.21823/2311-2905-2018-24-1-155-168.

3. Zengin A, Jarjou LM, Janha RE, et al. Sex-Specific Associations Between Cardiac Workload, Peripheral Vascular Calcification, and Bone Mineral Density: The Gambian Bone and Muscle Aging Study. J Bone Miner Res. 2021;36(2):227-35. doi:10.1002/jbmr.4196.

4. Xu X, Zhang M, Fei Z, et al. Calcification of lower extremity arteries is related to the presence of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a crosssectional observational study. Osteoporos Int. 2021;32(6):1185-93. doi:10.1007/s00198-020-05775-5.

5. Kokov AN, Masenko VL, Barbarash OL. Prognostic value of equivalent coronary artery calcium deposit density in men with osteopenic syndrome undergoing coronary artery bypass grafting: a prospective study. Therapeutic archive. 2022;94(4): 467-72.(In Russ.) doi:10.26442/00403660.2022.04.201463.

6. Muniyappa R, Tella S. Osteoporosis and cardiovascular disease in the elderly. Conn's Handbook of Models for Human Aging. 2nd ed. London/ San Diego/ Cambridge, MA/ Oxford: Elsevier Inc. 2018(2):721-33. ISBN: 978-0-12-811353-0. doi:10.1016/B978-0-12-811353-0.00053-1.

7. Myagkova MA, Skripnikova IA, Shalnova SA, et al. Associations of 10-year probability of osteoporotic fractures with total cardiovascular risk and atherosclerotic cardiovascular disease in urban and rural populations. Preventive medicine. 2021;4(6):18-27. (In Russ.) doi:10.17116/profmed20212406118.

8. Tankó LB, Christiansen C, Cox DA, et al. Relationship between osteo­porosis and cardiovascular disease in postmenopausal women. J Bone Min Res. 2005;20(11):1912-20. doi:10.1359/JBMR. 050711.

9. Mishra BH, Mishra PP, Mononen N, et al. Lipidomic architecture shared by subclinical markers of osteoporosis and athero­sclerosis: The Cardiovascular Risk in Young Finns Study. Bone. 2020;131:115-60. doi:10.1016/j.bone.2019.115160.

10. Lampropoulos CE, Papaioannou I, D’Cruz DP. Osteoporosis — A risk factor for cardiovascular disease? Nat Rev Rheumatol. 2012;8(10):587-98. doi:10.1038/nrrheum.2012.120.

11. Skripnikova IA, Alikhanova NA, Kolchina MA, et al. Athero­scle­rosis and osteoporosis. Common targets for the effects of cardiovascular and antiosteoporosis drugs (Part I). Effect of cardiovascular drugs on bone strength. Rational Pharmacotherapy in Cardiology. 2019;15(1):69-76. (In Russ.) doi:10.20996/1819-6446-2019-15-1-69-76.

12. Mangiafico RA, Alagona C, Pennisi P, et al. Increased aug­men­ta­tion index and central aortic blood pressure in osteoporotic post­menopausal women. Osteoporos Int. 2008;19(1):49-56. doi:10.1007/s00198-007-0438-5.

13. Rodríguez AJ, Scott D, Hodge A, et al. Associations between hip bone mineral density, aortic calcification and cardiac workload in community-dwelling older Australians. Osteoporos Int. 2017;28(7):2239-45. doi:10.1007/s00198-017-4024-1.

14. Tamaki J, Iki M, Hirano Y, et al. Low bone mass is associated with carotid atherosclerosis in postmenopausal women: the Japanese Populationbased Osteoporosis (JPOS) Cohort Study. Osteoporos Int. 2009;20(1):53-60. doi:10.1007/s00198-008-0633-z.

15. Jaalkhorol M, Fujita Y, Kouda K, et al. Low bone mineral density is associated with an elevated risk of developing increased arterial stiffness: A 10-year follow-up of Japanese women from the Japanese Populationbased Osteoporosis (JPOS) cohort study. Maturitas. 2019;119:39-45. doi:10.1016/j.maturitas.2018.11.001.

16. Alikhanova NA, Skripnikova IA, Tkacheva ON, et al. Association of vascular stiffness parameters and subclinical atherosclerosis with bone mass in postmenopausal women. Cardiovascular Therapy and Prevention. 2016;15(2):51-6. (In Russ.) doi:10.15829/1728-8800-2016-2-51-56.

17. Skripnikova IA, Kosmatova OV, Kolchina MA, et al. Evaluation of changes in bone mass and subclinical atherosclerosis in asymptomatic women over a 10-year period. Cardiovascular Therapy and Prevention. 2024;23(12):4246. (In Russ.) doi:10.15829/1728-8800-2024-4246. EDN: SOYTUX.

18. van Guldener C, Janssen MJF, Lambert J, et al. Endothelium-de­pen­dent vasodilatation is impaired in peritoneal dialysis pa­ti­ents. Nephrol Dial Transplant. 1998;13(7):1782-6. doi:10.1093/ndt/13.7.1782.

19. Griffin J, Yi-­Xiang J. Wang, Hua Zhou, et al. Redused bone per­fusion in osteoporosis: likely causes in an ovariectomy rat model. Radiology. 2010;254(3):739-46. doi:10.1148/radiol.09090608.

20. Khan ZA, Janssen I, Mazzarelli JK, et al. Serial Studies in Subclinical Atherosclerosis During Menopausal Transition (From the Study of Women’s Health Across the Nation). Am J Cardiol. 2018;122(7):1161-8. doi:10.1016/j.amjcard.2018.06.039.

21. Hamada M, Kajita E, Tamaki J, et al. Decreased bone mineral density and osteoporotic fractures are associated with the development of echogenic plaques in the carotid arteries over a 10-year followup period: The Japanese Populationbased Osteo­porosis (JPOS) Cohort Study. Maturitas. 2020;13:40-7. doi:10.1016/j.maturitas.2019.10.010.

22. Mohammadi А, Shateri К, Behzadi F, et al. Relationship between intima­media thickness and bone mineral density in postmenopausal women: a cross-sectional study. Int J Clin Exp Med. 2014; 7(12):5535-40.

23. Varri M, Tuomainen TP, Honkanen R, et al. Carotid intima-media thickness and calcification in relation to bone mineral density in postmenopausal womenthe ostprebba study. Maturitas. 2014; 78:304-9. doi:10.1016/j.maturitas.2014.05.017.

24. Ueki Y, Itagaki T, Kuwahara K. Lipidlowering Therapy and Coronary Plaque Regression. J Atheroscler Thromb. 2024;31(11): 1479-95. doi:10.5551/jat.RV22024.

25. Zhou Y-F, Wang Y, Wang G, et al. Association Between Statin Use and Progression of Arterial Stiffness Among Adults With High atherosclerotic Risk. JAMA Netw Open. 2022;5(6):e2218323. doi:10.1001/jamanetworkopen.2022.18323.